Protemix founder named NZ's 'biotechnologist of the year'
Tuesday, 15 March, 2005
Prof Garth Cooper, the president and chief scientist of Auckland-based Protemix, has been named NZBio's 'distinguished biotechnologist of the year' at the New Zealand biotech organisation's conference.
Cooper founded Protemix in 1999, when he had returned to Auckland after a spectacular career in the UK and US. While a Nuffield fellow at Oxford, he discovered the hormone amylin, and developed it into a new therapy for diabetes mellitus. He patented his discoveries and in 1987 founded biopharma company Amylin, which later listed on Nasdaq. Amylin's market capitalisation is now around US$2 billion.
He has stated that his aim in founding Protemix was to create New Zealand's first billion-dollar biotech company.
Accepting his award yesterday evening, Cooper issued a plea to funding bodies not to write off innovative science as mere "fishing expeditions", and put innovation at risk.
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
